KSIH yields 20000.00% · PFE yields 6.13%● Live data
📍 KSIH pulled ahead of the other in Year 1
Combined, KSIH + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KSIH + PFE for your $10,000?
KS International Holdings Corporation focuses on providing solutions and services to individuals seeking to become Internet-based retailers. It operates a Web site, kachingkaching.com, which provides individual Web Store owners with the ability to create, manage, and earn money from product sales generated from their individual online Web stores. The company provides Web Store owners with solutions and resources necessary to create, design, and maintain a Web Store; access to a range of retail goods at competitive prices; and order fulfillment, customer service, and other back-office functions, which assist Web Store Owners with tracking and managing orders and sales from their Web Stores. Its store products include books, DVDs, computers, software, kitchen products, home and garden products, pet supplies, cosmetics and fragrance products, health and wellness products, consumer electronics, cameras, and office supplies. The company was formerly known as KaChing KaChing, Inc. and changed its name to KS International Holdings Corporation in December 2013. KS International Holdings Corporation was founded in 2009 and is headquartered in Taipei City, Taiwan.
Full KSIH Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.